Bruce Kirkham
Impact in
- Rheumatology top 0.1%
- Spondyloarthritis Studies and Treatments
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Hematology top 0.2%
- Autoimmune and Inflammatory Disorders Research
Papers in
- Rheumatology 103
- Rheumatoid Arthritis Research and Therapies 66
- Spondyloarthritis Studies and Treatments 49
- Systemic Lupus Erythematosus Research 21
- Hematology 47
- Autoimmune and Inflammatory Disorders Research 47
- Co-authors
- Iain B. McInnesArthur KavanaughLeonie S. TaamsPhilip J. MeaseLuminita PricopShephard MpofuProton RahmanS. P. Oakley
- Journals
- Lara D. Veeken (22 papers)Annals of the Rheumatic Diseases (21 papers)The Journal of Rheumatology (5 papers)Arthritis & Rheumatology (5 papers)Clinical and Experimental Rheumatology (3 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Bruce Kirkham
138 papers receiving 7.0k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Rheumatology 4.1k
- Hematology 2.1k
- Immunology 3.9k
- Dermatology 656
- Pathology and Forensic Medicine 596
Countries citing papers authored by Bruce Kirkham
This map shows the geographic impact of Bruce Kirkham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce Kirkham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce Kirkham more than expected).
Fields of papers citing papers by Bruce Kirkham
This network shows the impact of papers produced by Bruce Kirkham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce Kirkham. The network helps show where Bruce Kirkham may publish in the future.
Co-authors
The 25 scholars most cited alongside Bruce Kirkham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 6 | |
| 6 | 2024 | 2 | |
| 7 | 2023 | 13 | |
| 8 | 2023 | 30 | |
| 9 | 2023 | 5 | |
| 10 | 2021 | 20 | |
| 11 | 2018 | 37 | |
| 12 | SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS OF ACTIVE PSORIATIC ARTHRITIS: LONG-TERM (4-YEAR) DATA FROM A PHASE 3 STUDY | 2018 | 1 |
| 13 | SECUKINUMAB IMPROVES MINIMAL DISEASE ACTIVITY RESPONSE RATES IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: DATA FROM PHASE 3 FUTURE-2 STUDY | 2016 | 1 |
| 14 | Secukinumab, a Human Anti-Interleukin-17A Monoclonal Antibody, Improves Active Psoriatic Arthritis and Inhibits Radiographic Progression: Efficacy and Safety Data from a Phase 3 Randomized, Multicenter, Double-Blind, Placebo-Controlled Study | 2014 | 12 |
| 15 | Secukinumab, a Human Anti-Interleukin-17A Monoclonal Antibody, Improves Active Psoriatic Arthritis: 24-Week Efficacy and Safety Data from a Phase 3 Randomized, Multicenter, Double-Blind, Placebo-Controlled Study Using Subcutaneous Dosing | 2014 | 19 |
| 16 | Secukinumab, a Human Anti-Interleukin-17A Monoclonal Antibody, Significantly Reduces Psoriasis Burden in Patients with Psoriatic Arthritis: Results from a Phase 3 Randomized Controlled Trial | 2014 | 12 |
| 17 | Measurement of mucosal wetness in patients with xerostomia | 2010 | 1 |
| 18 | Synovial macrophages as a biomarker of response to therapeutic intervention in rheumatoid arthritis: standardization and consistency across centers. | 2007 | 58 |
| 19 | 2006 | 133 | |
| 20 | 2005 | 49 |
About Bruce Kirkham
Bruce Kirkham is a scholar working on Rheumatology, Hematology, Immunology, Dermatology and Pathology and Forensic Medicine, having authored 143 papers that have together received 7.2k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (66 papers), Psoriasis: Treatment and Pathogenesis (55 papers), Spondyloarthritis Studies and Treatments (49 papers), Autoimmune and Inflammatory Disorders Research (47 papers), Systemic Lupus Erythematosus Research (21 papers), T-cell and B-cell Immunology (13 papers), Dermatology and Skin Diseases (8 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). The work is most often cited by research in Rheumatology (4.1k citations), Hematology (2.1k citations), Immunology (3.9k citations), Dermatology (656 citations) and Pathology and Forensic Medicine (596 citations). Bruce Kirkham has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Iain B. McInnes, Arthur Kavanaugh, Leonie S. Taams, Philip J. Mease, Luminita Pricop, Shephard Mpofu, Proton Rahman, S. P. Oakley, Paul Bird and Désirée van der Heijde. Their work appears in journals such as Lara D. Veeken, Annals of the Rheumatic Diseases, The Journal of Rheumatology, Arthritis & Rheumatology and Clinical and Experimental Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.